Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | KIND T cells |
Trade Name | |
Synonyms | |
Drug Descriptions |
KIND T cells are HLA-A2+ CD8+ T-lymphocytes engineered to express a T-cell receptor (TCR) targeting the histone H3.3 K27M (K28M) mutation, which potentially induce killing of tumor cells expressing HLA-A2+ and H3.3K27M (PMID: 29203539). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
KIND T cells | KIND T cells | 0 | 1 |